Sameer Raina, MD
Cardiovascular Disease (Cardiology) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Raina’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A139638 · Current
Licensed to practise in California · since 2015 · expires 2027-08-31 · Maharashtra University of Health Sciences, Armed Forces Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$111,662
Medicare paid this office $111,662 for 1,692 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 154 | $26,561 | $118 |
| New patient visit (60+ min) | 115 | $24,322 | $211 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 51 | $10,694 | $210 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 61 | $9,836 | $70 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,114 | $9,586 | $7 |
See all 16 services
| Return visit (30+ min) | 154 | $26,561 | $118 |
| New patient visit (60+ min) | 115 | $24,322 | $211 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 51 | $10,694 | $210 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 61 | $9,836 | $70 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,114 | $9,586 | $7 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 71 | $8,326 | $113 |
| New patient visit (45+ min) | 35 | $4,912 | $140 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 146 | $3,598 | $24 |
| Hospital discharge day management, more than 30 minutes | 30 | $3,411 | $110 |
| Long return visit (40+ min) | 21 | $3,343 | $152 |
| Injection, perflutren lipid microspheres, per ml | 13 | $862 | $33 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $830 | $75 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 35 | $508 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 19 | $342 | $18 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 14 | $284 | $20 |
| Injection, dobutamine hydrochloride, per 250 mg | 31 | $212 | None |
Who their Medicare patients are
1,692 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 17% · Women 51% · Also on Medicaid 30% · Health risk score 2.03. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 48% · Atrial fibrillation 42% · Heart failure 39% · Chronic kidney disease 39% · Diabetes 38% · Depression 25% · Cancer 23% · COPD 18% · Stroke 17% · Dementia 16%.
The office billed $567,346, Medicare allowed $147,767 and paid $111,662; for 2,669 services of 35 kinds; $1,097 of it was for drugs given in the office and $110,565 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,692 | 2,669 | 75 | 2.03 | $567,346 | $111,662 |
| 2023 | 843 | 1,157 | 75 | 2.03 | $246,624 | $52,994 |
| 2022 | 879 | 1,428 | 73 | 1.88 | $259,902 | $66,774 |
| 2021 | 855 | 1,423 | 72 | 2.07 | $268,511 | $72,299 |
| 2020 | 1,083 | 1,745 | 71 | 2.30 | $337,303 | $90,879 |
| 2019 | 1,241 | 2,142 | 71 | 2.44 | $404,455 | $106,246 |
| 2018 | 1,406 | 2,645 | 71 | 2.16 | $474,312 | $130,272 |
| 2017 | 1,795 | 3,368 | 71 | 2.21 | $463,398 | $121,847 |
| 2016 | 915 | 1,504 | 70 | 2.08 | $183,275 | $45,329 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Long return visit (40+ min) | 47 | $8,040 | $171 |
| New patient visit (60+ min) | 37 | $7,588 | $205 |
| New patient visit (45+ min) | 36 | $5,757 | $160 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 85 | $3,928 | $46 |
| Return visit (30+ min) | 27 | $3,415 | $122 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,153 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $3,116 | $58 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 379 | $3,081 | $7 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $1,602 | $114 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $1,487 | $83 |
| Return visit (30+ min) | 31 | $1,472 | $47 |
| Hospital discharge day management, 30 minutes or less | 23 | $1,378 | $57 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 35 | $838 | $24 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $536 | $45 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 23 | $277 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $181 | $14 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $120 | $9 |
| Injection, dobutamine hydrochloride, per 250 mg | 12 | $90 | None |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $36 | $2 |
2022: 21 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 315 | $15,293 | $48 |
| Ultrasound of heart with probe in esophagus, with report | 82 | $6,936 | $85 |
| Return visit (30+ min) | 85 | $5,825 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $5,305 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $4,807 | $76 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 55 | $4,622 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 37 | $3,910 | $106 |
| New patient visit (45+ min) | 36 | $3,596 | $100 |
| Hospital discharge day management, 30 minutes or less | 40 | $2,145 | $54 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 26 | $2,051 | $79 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 133 | $2,039 | $15 |
| External shock to heart to regulate heart beat | 24 | $2,030 | $85 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 37 | $2,004 | $54 |
| Ultrasound of heart blood flow, valves and chambers | 61 | $851 | $14 |
| Short return visit (20+ min) | 18 | $835 | $42 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 63 | $621 | $10 |
| 3d ultrasound imaging of heart for evaluation of heart structure performed during ultrasound imaging of congenital heart defects | 27 | $535 | $20 |
| Ultrasound of heart, follow-up | 27 | $416 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 39 | $387 | $10 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 50 | $251 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 81 | $188 | $2 |
2021: 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 338 | $17,357 | $51 |
| Return visit (30+ min) | 90 | $7,257 | $68 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $7,094 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 75 | $6,791 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 50 | $5,285 | $106 |
| Hospital discharge day management, 30 minutes or less | 81 | $4,575 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $4,471 | $81 |
| Ultrasound of heart with probe in esophagus, with report | 45 | $3,813 | $85 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 53 | $2,997 | $57 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 31 | $2,483 | $80 |
| New patient visit (45+ min) | 26 | $2,092 | $80 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 74 | $1,082 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 86 | $923 | $11 |
| Ultrasound of heart, follow-up | 45 | $883 | $19 |
| Short return visit (20+ min) | 15 | $600 | $40 |
| Ultrasound of heart blood flow, valves and chambers | 39 | $517 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 57 | $325 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 77 | $180 | $2 |
| 3d radiographic procedure | 22 | $162 | $7 |
2020: 20 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 505 | $27,780 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $12,220 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $6,894 | $83 |
| Return visit (30+ min) | 90 | $5,843 | $56 |
| Ultrasound of heart with probe in esophagus, with report | 64 | $5,498 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $5,102 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 45 | $4,959 | $110 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 79 | $4,583 | $58 |
| Hospital discharge day management, 30 minutes or less | 70 | $4,042 | $57 |
| New patient visit (45+ min) | 32 | $2,790 | $87 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 30 | $2,546 | $82 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 111 | $1,761 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 112 | $1,196 | $11 |
| Ultrasound of heart, follow-up | 38 | $785 | $20 |
| Ultrasound of heart blood flow, valves and chambers | 39 | $545 | $14 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 57 | $338 | $6 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $329 | $30 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $210 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 85 | $209 | $2 |
| 3d radiographic procedure | 23 | $177 | $8 |
2019: 22 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 671 | $33,934 | $50 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $12,320 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $10,692 | $82 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 77 | $8,511 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 66 | $6,680 | $57 |
| Ultrasound of heart with probe in esophagus, with report | 80 | $6,467 | $79 |
| Return visit (30+ min) | 73 | $4,934 | $57 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 83 | $4,913 | $59 |
| Hospital discharge day management, 30 minutes or less | 73 | $4,200 | $57 |
| New patient visit (45+ min) | 28 | $2,642 | $94 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 22 | $1,764 | $80 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 114 | $1,747 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 99 | $1,072 | $11 |
| Ultrasound of heart, follow-up | 53 | $953 | $17 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 17 | $852 | $50 |
| Ultrasound of heart blood flow, valves and chambers | 59 | $809 | $14 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 48 | $442 | $9 |
| Injection of x-ray contrast during ultrasound of heart | 15 | $324 | $22 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 61 | $323 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 120 | $282 | $2 |
| 3d radiographic procedure | 23 | $156 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 24 | $149 | $6 |
2018: 26 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 704 | $38,630 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 93 | $15,212 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $13,251 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 97 | $10,767 | $57 |
| Ultrasound of heart with probe in esophagus, with report | 107 | $8,530 | $80 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 71 | $7,792 | $107 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 124 | $7,616 | $61 |
| Hospital discharge day management, 30 minutes or less | 83 | $4,790 | $56 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 200 | $3,411 | $17 |
| Return visit (30+ min) | 37 | $2,393 | $58 |
| Short return visit (20+ min) | 58 | $2,291 | $35 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 26 | $2,227 | $80 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 157 | $1,805 | $11 |
| External shock to heart to regulate heart beat | 14 | $1,144 | $82 |
| New patient visit (45+ min) | 12 | $1,112 | $93 |
| Ultrasound of heart, follow-up | 52 | $966 | $18 |
| Ultrasound of heart blood flow, valves and chambers | 62 | $872 | $14 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $796 | $66 |
| New patient visit (30+ min) | 13 | $719 | $55 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 12 | $570 | $47 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 85 | $455 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 148 | $357 | $2 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 52 | $325 | $6 |
| Injection of x-ray contrast during ultrasound of heart | 13 | $315 | $24 |
| 3d radiographic procedure | 35 | $243 | $7 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $151 | $10 |
2017: 26 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 500 | $22,490 | $45 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 88 | $13,789 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 85 | $12,904 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 131 | $12,608 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 91 | $10,001 | $105 |
| Ultrasound of heart with probe in esophagus, with report | 81 | $7,066 | $83 |
| Hospital discharge day management, 30 minutes or less | 119 | $6,803 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 672 | $5,291 | $6 |
| Short return visit (20+ min) | 122 | $4,964 | $34 |
| Return visit (30+ min) | 60 | $3,781 | $56 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 42 | $3,300 | $79 |
| Ultrasound of heart, follow-up | 147 | $3,045 | $19 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 43 | $2,481 | $58 |
| Initial hospital observation care per day, typically 50 minutes | 15 | $1,574 | $105 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 90 | $1,366 | $15 |
| External shock to heart to regulate heart beat | 15 | $1,278 | $85 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 182 | $1,108 | $5 |
| New patient visit (30+ min) | 18 | $964 | $54 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 12 | $661 | $55 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 13 | $642 | $49 |
| Hospital observation care on day of discharge | 11 | $613 | $56 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 219 | $568 | $2 |
| Ultrasound of heart blood flow, valves and chambers | 38 | $538 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 22 | $240 | $11 |
| 3d radiographic procedure | 17 | $138 | $8 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 11 | $72 | $7 |
2016: 18 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 264 | $12,746 | $48 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $3,917 | $151 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 419 | $3,552 | $6 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,157 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $2,232 | $80 |
| Ultrasound of heart with probe in esophagus, with report | 23 | $2,156 | $94 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 26 | $2,115 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $1,875 | $55 |
| Ultrasound of heart, follow-up | 89 | $1,823 | $19 |
| Hospital discharge day management, 30 minutes or less | 28 | $1,588 | $55 |
| Return visit (30+ min) | 19 | $1,260 | $60 |
| New patient visit (45+ min) | 12 | $1,201 | $100 |
| Short return visit (20+ min) | 28 | $1,085 | $36 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 102 | $597 | $6 |
| New patient visit (30+ min) | 11 | $557 | $51 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 112 | $277 | $2 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 16 | $274 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 13 | $85 | $7 |
Medicaid work
$12,847 in 2024
Medicaid paid $12,847 for 1,013 billed services this clinician did in 2024, up to 262 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 883 | $9,799 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 56 | $1,302 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 60 | $1,289 |
| Return visit (30+ min) | 14 | $457 |
| 2024 | 1,013 | 4 | 262 | $12,847 |
| 2023 | 388 | 2 | 126 | $4,416 |
| 2022 | 97 | 1 | 27 | $2,496 |
| 2021 | 225 | 1 | 24 | $8,349 |
| 2020 | 274 | 1 | 26 | $13,614 |
| 2019 | 160 | 1 | 43 | $6,011 |
| 2018 | 574 | 8 | 73 | $26,474 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 373 | $3,999 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 15 | $417 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 97 | $2,496 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 225 | $8,349 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 274 | $13,614 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 160 | $6,011 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 389 | $17,665 |
| CARDIOVASCULAR STRESS TEST | 64 | $3,156 |
| CARDIOVASCULAR STRESS TEST | 32 | $1,727 |
| ECHO TRANSESOPHAGEAL | 15 | $1,144 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 23 | $1,006 |
| 1ST HOSP IP/OBS HIGH 75 | 13 | $703 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 18 | $701 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 20 | $372 |
Drugs they prescribed that Part D paid
$223,351
Pharmacies billed $223,351 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,042) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
835 generic and fewer than 11 brand-name prescriptions · $223,351 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 45 | $51,840 | $1,152 |
| Eliquis | 47 | $49,675 | $1,057 |
| Xarelto | 29 | $43,445 | $1,498 |
| Repatha Sureclick | 26 | $23,122 | $889 |
| Jardiance | 15 | $20,799 | $1,387 |
See all 23 drugs
| Farxiga | 45 | $51,840 | $1,152 |
| Eliquis | 47 | $49,675 | $1,057 |
| Xarelto | 29 | $43,445 | $1,498 |
| Repatha Sureclick | 26 | $23,122 | $889 |
| Jardiance | 15 | $20,799 | $1,387 |
| Praluent | 19 | $14,051 | $740 |
| Metoprolol | 134 | $2,001 | $15 |
| Ezetimibe | 37 | $1,817 | $49 |
| Rosuvastatin | 69 | $950 | $14 |
| Atorvastatin | 129 | $868 | $7 |
| Amlodipine Besylate | 71 | $637 | $9 |
| Diltiazem 24hr Er (Cd) | 17 | $546 | $32 |
| Isosorbide Mononitrate Er | 17 | $443 | $26 |
| Losartan | 51 | $407 | $8 |
| Furosemide | 39 | $334 | $9 |
| Carvedilol | 36 | $317 | $9 |
| Amiodarone | 13 | $266 | $20 |
| Metoprolol | 16 | $211 | $13 |
| Potassium Chloride | 13 | $180 | $14 |
| Spironolactone | 18 | $131 | $7 |
| Hydrochlorothiazide | 18 | $119 | $7 |
| Lisinopril | 22 | $117 | $5 |
| Atenolol | 14 | $29 | $2 |
Year by year
| 2024 | 1,042 | 211 | 0% (0) | None | $223,351 |
| 2023 | 411 | 136 | 0% (0) | 15% | $80,898 |
| 2022 | 210 | 72 | 0% (0) | None | $24,638 |
| 2021 | 142 | 37 | 0% (0) | None | $11,738 |
| 2020 | 148 | 38 | 0% (0) | None | $8,008 |
| 2019 | 73 | 33 | 0% (0) | 19% | $6,351 |
| 2018 | 227 | 66 | 0% (0) | 13% | $9,796 |
| 2017 | 530 | 96 | 0% (0) | 22% | $26,018 |
| 2016 | 140 | 46 | None | 12% | $3,560 |
| 2015 | 198 | 30 | None | None | $4,031 |
| 2014 | 248 | 37 | None | None | $4,924 |
| 2013 | 672 | 36 | 5% (35) | None | $26,855 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Farxiga | 28 | $29,700 | $1,061 |
| Ezetimibe | 23 | $1,428 | $62 |
| Metoprolol | 62 | $1,106 | $18 |
| Atorvastatin | 49 | $1,039 | $21 |
| Rosuvastatin | 23 | $779 | $34 |
| Amlodipine Besylate | 32 | $432 | $13 |
| Furosemide | 26 | $230 | $9 |
| Isosorbide Mononitrate Er | 11 | $189 | $17 |
| Lisinopril | 15 | $102 | $7 |
| Clopidogrel | 14 | $92 | $7 |
2022: 5 drugs
| Eliquis | 12 | $6,816 | $568 |
| Metoprolol | 49 | $1,065 | $22 |
| Valsartan | 12 | $338 | $28 |
| Furosemide | 15 | $80 | $5 |
| Lisinopril | 15 | $44 | $3 |
2021: 4 drugs
| Eliquis | 12 | $6,294 | $525 |
| Metoprolol | 16 | $341 | $21 |
| Carvedilol | 13 | $162 | $12 |
| Amlodipine Besylate | 12 | $18 | $2 |
2020: 4 drugs
| Diltiazem 24hr Er (Cd) | 13 | $462 | $36 |
| Metoprolol | 16 | $287 | $18 |
| Lisinopril | 13 | $151 | $12 |
| Clopidogrel | 11 | $64 | $6 |
2018: 6 drugs
| Atorvastatin | 26 | $381 | $15 |
| Isosorbide Mononitrate Er | 21 | $158 | $8 |
| Warfarin | 14 | $144 | $10 |
| Furosemide | 20 | $75 | $4 |
| Metoprolol | 11 | $72 | $7 |
| Lisinopril | 16 | $45 | $3 |
2017: 15 drugs
| Eliquis | 12 | $4,143 | $345 |
| Metoprolol | 58 | $2,066 | $36 |
| Rosuvastatin | 23 | $958 | $42 |
| Atorvastatin | 40 | $557 | $14 |
| Diltiazem 24hr Er | 14 | $439 | $31 |
| Lisinopril | 59 | $277 | $5 |
| Clopidogrel | 18 | $226 | $13 |
| Warfarin | 19 | $202 | $11 |
| Isosorbide Mononitrate Er | 12 | $191 | $16 |
| Metoprolol | 27 | $188 | $7 |
| Carvedilol | 24 | $178 | $7 |
| Enalapril Maleate | 12 | $140 | $12 |
| Furosemide | 35 | $109 | $3 |
| Amlodipine Besylate | 19 | $106 | $6 |
| Spironolactone | 12 | $42 | $3 |
2016: 4 drugs
| Metoprolol | 20 | $548 | $27 |
| Atorvastatin | 15 | $136 | $9 |
| Lisinopril | 18 | $72 | $4 |
| Carvedilol | 19 | $67 | $4 |
2015: 5 drugs
| Hydralazine | 15 | $328 | $22 |
| Atorvastatin | 23 | $230 | $10 |
| Carvedilol | 28 | $123 | $4 |
| Lisinopril | 14 | $42 | $3 |
| Amlodipine Besylate | 11 | $31 | $3 |
2014: 9 drugs
| Atorvastatin | 21 | $210 | $10 |
| Lisinopril | 18 | $163 | $9 |
| Clopidogrel | 13 | $132 | $10 |
| Omeprazole | 12 | $87 | $7 |
| Atenolol | 20 | $77 | $4 |
| Benazepril | 12 | $68 | $6 |
| Amlodipine Besylate | 14 | $65 | $5 |
| Simvastatin | 13 | $61 | $5 |
| Metoprolol | 16 | $50 | $3 |
2013: 20 drugs
| Nifedipine Er | 26 | $1,307 | $50 |
| Proair Hfa | 17 | $1,303 | $77 |
| Potassium Chloride | 27 | $955 | $35 |
| Gabapentin | 24 | $844 | $35 |
| Metoprolol | 16 | $711 | $44 |
| Lisinopril | 41 | $373 | $9 |
| Omeprazole | 12 | $357 | $30 |
| Glipizide | 13 | $252 | $19 |
| Tramadol | 29 | $204 | $7 |
| Pravastatin | 32 | $192 | $6 |
| Losartan | 18 | $168 | $9 |
| Metformin | 22 | $167 | $8 |
| Furosemide | 25 | $155 | $6 |
| Chlorthalidone | 11 | $138 | $13 |
| Spironolactone | 12 | $99 | $8 |
| Simvastatin | 11 | $86 | $8 |
| Hydrochlorothiazide | 29 | $74 | $3 |
| Enalapril Maleate | 12 | $63 | $5 |
| Paroxetine | 11 | $44 | $4 |
| Amitriptyline | 11 | $36 | $3 |
Money from drug and device companies
$446 in 2025
| 2025 | 2 | 3 | None | $446 |
| 2022 | 2 | 2 | None | $108 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Heartflow | Ffrct | $347 | 2 payments
|
| Novartis Pharmaceuticals | Leqvio | $99 | 1 payment
|
See all 3 published payments
| Heartflow | Meals · 2025-11-24 | Ffrct | $4 |
| Novartis Pharmaceuticals | Meals · 2025-11-09 | Leqvio | $99 |
| Heartflow | Meals · 2025-06-26 | Ffrct | $343 |
See earlier years (2022)
2022: $108
| Roche Diagnostics | None | $90 | 1 payment
|
| Lantheus Medical Imaging | Definity | $18 | 1 payment
|
Professional record
- NPI
- 1063729580
- Licence
- CA A139638, WV 26972California A139638: Current · expires 2027-08-31
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Federal specialty code 207UN0901X (207UN0901X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2010-09-03
- NPI last updated
- 2024-04-24
- NPI record certified
- 2024-04-24
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4301 W Markham St, Little Rock, AR, 72205 · 1 Medical Center Dr, Morgantown, WV, 26506
This office lists an electronic records connection.